DNAtriX Obtains $72,500 New Funding

  • Feed Type
  • Date
    6/30/2011
  • Company Name
    DNAtriX
  • Mailing Address
    One Greenway Plaza Houston, TX 77046
  • Company Description
    DNAtriX, Inc. is a Texas-based biotechnology company focused on the development of an oncoloytic virus platform initially for the treatment of malignant glioma. DNAtriX’s lead product, delta24RGD, is a next-generation adenovirus invented by company founder Dr. Juan Fueyo and Dr. Frank McCormick.
  • Website
    http://www.dnatrix.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $72,500
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    DFJ Mercury

Trending on Xconomy